Proefschrift

Merlo, L., Pepper, J., Reid, B., and Maley, C. (2006). Cancer as an evolutionary and ecological process. Nature Reviews Cancer , 6(12):924–935. 9, 11, 81 Metz, J., Stanˇkova´, K., and Johansson, J. (2016). The adaptive dynamics of life histories: From fitness-returns to selection gradients and Pontryagin’s maximum principle. Journal of Mathematical Biology , 72(4):1125–1152. 141 Michod, R. and Roze, D. (2001). Cooperation and conflict in the evolution of multicellularity. Heredity , 86(1):1–7. 3 Michor, F. and Beal, K. (2015). Improving cancer treatment via mathematical modeling: surmounting the challenges is worth the effort. Cel l , 163(5):1059–1063. 3 Michor, F., Nowak, M., and Iwasa, Y. (2006). Evolution of resistance to cancer therapy. Current Pharmaceutical Design , 12(3):261–271. 5 Midingoyi, S.-k., Kassie, M., Muriithi, B., Diiro, G., and Ekesi, S. (2019). Do farmers and the environment benefit from adopting integrated pest management practices? evidence from kenya. Journal of Agricultural Economics , 70(2):452–470. 9 Mitin, T., Efstathiou, J., and Shipley, W. (2012). Urological cancer: The benefits of intermittent androgen-deprivation therapy. Nature Reviews Clinical Oncology , 9(12):672– 673. 104 Miyamoto, D., Lee, R., Stott, S., Ting, D., Wittner, B., Ulman, M., Smas, M., Lord, J., Brannigan, B., Trautwein, J., et al. (2012). Androgen receptor signaling in circulating tumor cells as a marker of hormonally responsive prostate cancer. Cancer Discovery , 2(11):995–1003. 113 Miyamoto, D., Zheng, Y., Wittner, B., Lee, R., Zhu, H., Broderick, K., Desai, R., Fox, D., Brannigan, B., Trautwein, J., et al. (2015). RNA-Seq of single prostate CTCs implicates noncanonical Wnt signaling in antiandrogen resistance. Science , 349(6254):1351–1356. 113 Moen, I. and Stuhr, L. (2012). Hyperbaric oxygen therapy and cancer—a review. Targeted Oncology , 7(4):233–242. 21 Mohler, J., Gregory, C., Ford III, O., Kim, D., Weaver, C., Petrusz, P., Wilson, E., and French, F. (2004). The androgen axis in recurrent prostate cancer. Clinical Cancer Research , 10(2):440–448. 28 Montagna, E., Cancello, G., Dellapasqua, S., Munzone, E., and Colleoni, M. (2014). Metronomic therapy and breast cancer: A systematic review. Cancer Treatment Review , 40:942–950. 75 Montgomery, R., Mostaghel, E., Vessella, R., Hess, D., Kalhorn, T., Higano, C., True, L., and Nelson, P. (2008). Maintenance of intratumoral androgens in metastatic prostate cancer: a mechanism for castration-resistant tumor growth. Cancer Research , 68(11):4447–4454. 28, 49 180